Shop

Showing 881–896 of 1289 results

Article: O.08 ULTRA-DEEP TARGETED RESEQUENCING REVEALS RECURRENT DAXX AND CYFIP2 MUTATIONS AND IMPLICATES NOVEL PATHWAYS IN PANCREATIC NEUROENDOCRINE TUMORS
€3.03 Add to cart
Article: O.09 Geriatric assessment (GA)- guided interventions in older patients (pts) with cancer
€3.03 Add to cart
Article: O.09 GLIOBLASTOMA MULTIFORME (GBM): STUPP AND REALITY
€3.03 Add to cart
Article: O.10 Cardiotoxicity of immune checkpoint inhibitors (ICI): a systematic review and meta-analysis of randomized clinical trials
€3.03 Add to cart
Article: O.10 THE DEUBIQUITINASE USP13 AS A NOVEL THERAPEUTIC CO-TARGET IN EGFR MUTANT NON-SMALL CELL LUNG CANCER
€3.03 Add to cart
Article: O.10 USP13 as a novel co-target for EGFR targeted therapies in EGFR mutant non-small cell lung cancer
€3.03 Add to cart
Article: O.11 Cyclin dependent kinase inhibitors (CDK4-6i) as adjuvant treatment for patients (pts) with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (EBC): a systematic review and meta-analysis
€3.03 Add to cart
Article: O.12 Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer
€3.03 Add to cart
Article: O.13 Colchicine as salvage for refractory pyrexia due to BRAF and MEK inhibitors: a case report
€3.03 Add to cart
Article: O.19 Overall survival improvement in metastatic clear-cell renal cell carcinoma patients from 2000 to 2020
€3.03 Add to cart
Article: O01 SPATIAL ORGANIZATION OF THE IMMUNE MICROENVIRONMENT AFTER NEOADJUVANT TREATMENT OF BREAST CANCER
€3.03 Add to cart
Article: O02 IMMUNE-RELATED ADVERSE EVENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS IN A REAL-WORLD SCENARIO
€3.03 Add to cart
Article: O03 SJÖGREN’S SYNDROME INDUCED BY IMMUNE CHECKPOINT INHIBITORS: CASE REPORT OF TWO PATIENTS AND REVIEW OF THE LITERATURE
€3.03 Add to cart
Article: O04 MICROENVIRONMENT-MEDIATED LIPID METABOLISM REPROGRAMMING AND ANTI-EGFR THERAPY RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
€3.03 Add to cart
Article: O05 DETECTION OF CIRCULATING TUMOR DNA (CTDNA) POST NEOADJUVANT CHEMOTHERAPY (NACT) USING A PERSONALIZED ASSAY IN PATIENTS (PTS) WITH EARLY BREAST CANCER (EBC) IS ASSOCIATED WITH DISEASE RELAPSE
€3.03 Add to cart
Article: O06 EMOTIONAL FREEDOM TECHNIQUES AS AN EFFECTIVE STRATEGY FOR TREATMENT OF SELF-REPORTED CANCER-RELATED COGNITIVE IMPAIRMENT IN CANCER SURVIVORS (EMOTICON)
€3.03 Add to cart

Article: O.08 ULTRA-DEEP TARGETED RESEQUENCING REVEALS RECURRENT DAXX AND CYFIP2 MUTATIONS AND IMPLICATES NOVEL PATHWAYS IN PANCREATIC NEUROENDOCRINE TUMORS

Article: O.09 Geriatric assessment (GA)- guided interventions in older patients (pts) with cancer

Article: O.09 GLIOBLASTOMA MULTIFORME (GBM): STUPP AND REALITY

Article: O.10 Cardiotoxicity of immune checkpoint inhibitors (ICI): a systematic review and meta-analysis of randomized clinical trials

Article: O.10 THE DEUBIQUITINASE USP13 AS A NOVEL THERAPEUTIC CO-TARGET IN EGFR MUTANT NON-SMALL CELL LUNG CANCER

Article: O.10 USP13 as a novel co-target for EGFR targeted therapies in EGFR mutant non-small cell lung cancer

Article: O.11 Cyclin dependent kinase inhibitors (CDK4-6i) as adjuvant treatment for patients (pts) with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (EBC): a systematic review and meta-analysis

Article: O.12 Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer

Article: O.13 Colchicine as salvage for refractory pyrexia due to BRAF and MEK inhibitors: a case report

Article: O.19 Overall survival improvement in metastatic clear-cell renal cell carcinoma patients from 2000 to 2020

Article: O01 SPATIAL ORGANIZATION OF THE IMMUNE MICROENVIRONMENT AFTER NEOADJUVANT TREATMENT OF BREAST CANCER

Article: O02 IMMUNE-RELATED ADVERSE EVENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS IN A REAL-WORLD SCENARIO

Article: O03 SJÖGREN’S SYNDROME INDUCED BY IMMUNE CHECKPOINT INHIBITORS: CASE REPORT OF TWO PATIENTS AND REVIEW OF THE LITERATURE

Article: O04 MICROENVIRONMENT-MEDIATED LIPID METABOLISM REPROGRAMMING AND ANTI-EGFR THERAPY RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Article: O05 DETECTION OF CIRCULATING TUMOR DNA (CTDNA) POST NEOADJUVANT CHEMOTHERAPY (NACT) USING A PERSONALIZED ASSAY IN PATIENTS (PTS) WITH EARLY BREAST CANCER (EBC) IS ASSOCIATED WITH DISEASE RELAPSE

Article: O06 EMOTIONAL FREEDOM TECHNIQUES AS AN EFFECTIVE STRATEGY FOR TREATMENT OF SELF-REPORTED CANCER-RELATED COGNITIVE IMPAIRMENT IN CANCER SURVIVORS (EMOTICON)